Jaume Reventós Puigjaner

Title: Jaume Reventós Puigjaner: Innovator in Endometrial Cancer Detection

Introduction

Jaume Reventós Puigjaner is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medical diagnostics, particularly in the detection of endometrial cancer. His innovative work has the potential to improve early detection and treatment outcomes for patients.

Latest Patents

Jaume Reventós Puigjaner holds a patent for "Markers for endometrial cancer." This invention is based on the discovery that specific biomarkers, including ACAA1, AP1M2, CGN, DDR1, EPS8L2, FASTKD1, GMIP, IKBKE, P2RX4, P4HB, PHKG2, PPFIBP2, PPP1 R16A, RASSF7, RNF183, SIRT6, TJP3, EFEMP2, S0CS2, and DCN, are differentially expressed in samples from patients with endometrial cancer compared to control samples. These biomarkers demonstrate excellent sensitivity and specificity, making them valuable for detecting the disease. Furthermore, the correlation between biomarker expression in tumor tissue and uterine fluid samples enhances their robustness in clinical applications.

Career Highlights

Jaume Reventós Puigjaner is associated with Geadic Biotec, a company focused on biotechnological advancements. His work at Geadic Biotec has allowed him to further develop his research and contribute to innovative solutions in cancer diagnostics.

Collaborations

Jaume has collaborated with notable colleagues, including Miguel Abal Posada and Andreas Doll. These partnerships have fostered a collaborative environment that enhances the research and development of new diagnostic tools.

Conclusion

Jaume Reventós Puigjaner is a pioneering inventor whose work in endometrial cancer detection is paving the way for advancements in medical diagnostics. His contributions are crucial for improving patient outcomes and enhancing the accuracy of cancer detection methods.